在2名患有伯纳德-索利耶综合征的兄弟中进行重组因子VIIa预防
Eman Almatar1, Sondus Alsharidah1, Omnia A Hashem1
1Department of Hematology, NBK Specialized Children's Hospital, Kuwait City, Kuwait.
The American journal of case reports
|November 19, 2025
概括
预防性复合激活因子VIIa (rFVIIa) 有效降低了两个患有伯纳德-苏利耶综合征 (BSS) 的兄弟的出血. 这为治疗严重BSS出血发作提供了血小板输血的潜在替代方案.
科学领域:
- 血液学 血液学 血液学
- 罕见疾病 罕见疾病
- 血栓形成和血液静止.
背景情况:
- 伯纳德-苏利尔综合征 (BSS) 是一种罕见的自体逆性血小板疾病.
- 由于糖蛋白1b-IX-V复合物的异常,特征是血栓缩,巨型血小板,长时间出血和血小板粘附缺陷.
- 由于严重出血风险和血小板输血并发症,管理具有挑战性.
研究的目的:
- 评估预防性复合激活因子VIIa (rFVIIa) 在治疗重复出血的严重伯纳德-索利耶综合征的兄弟姐妹的疗效.
- 探索rFVIIa作为血小板输血的潜在替代品.
主要方法:
- 病例报告:两名兄弟患有严重的BSS和反复出现的粘膜皮肤出血.
- 开始每周预防性静脉注射rFVIIa (分别为4.5mg和4mg).
主要成果:
- 两位患者在开始预防性rFVIIa后,出血发作的频率和严重程度显著降低.
- 治疗耐受性很好,显示出出血控制的明显改善.
结论:
- 预防性rFVIIa的使用在减轻严重BSS.兄弟姐妹的出血事件方面表现出有效性.
- 强调rFVIIa作为重复出血患者血小板输血的可行替代方案的潜力.
- 需要进一步的研究,以建立在BSS中的预防性rFVIIa使用的标准化协议.
相关概念视频
Venous Thrombosis III: Interprofessional Care
268
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
268
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
Venous Thrombosis IV: Nursing Management
188
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
188
Venous Thrombosis I: Introduction
321
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
321


